Clinical Trial Update: A Trial of TBL12 Sea Cucumber Extract in Patients With Untreated Asymptomatic Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating TBL12 Sea Cucumber Extract in untreated asymptomatic myeloma was terminated, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Smoldering Multiple Myeloma

Drugs mentioned

• TBL12 Sea Cucumber Extract

Snippet

Sponsor: NYU Langone Health | Conditions: Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2015-02-12